Dale Chow - Aspira Womens President

AWH Stock  USD 3.43  0.07  2.00%   

President

Mr. Dale Chow was appointed as Senior Vice President Professional Lines of Allied World Bermuda of the Company. Mr. Chow has over 23 years of experience with management, professional and transactional lines of business. He joins Allied World from Endurance Insurance Bermuda, where he served as a Senior Vice President within the professional lines division. Prior to joining Endurance, he worked at Chubb in Vancouver, Canada. since 2016.
Tenure 8 years
Address Building III, Austin, TX, United States, 78738
Phone512 519 0400
Webhttps://aspirawh.com

Aspira Womens Management Efficiency

The company has Return on Asset of (0.7594) % which means that on every $100 spent on assets, it lost $0.7594. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (3.4589) %, meaning that it generated no profit with money invested by stockholders. Aspira Womens' management efficiency ratios could be used to measure how well Aspira Womens manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Capital Employed is estimated to decrease to -3.41. The current Return On Assets is estimated to decrease to -1.5. As of now, Aspira Womens' Fixed Asset Turnover is increasing as compared to previous years.
The company has 3.83 M in debt with debt to equity (D/E) ratio of 0.25, which may show that the company is not taking advantage of profits from borrowing. Aspira Womens Health has a current ratio of 3.19, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Aspira Womens until it has trouble settling it off, either with new capital or with free cash flow. So, Aspira Womens' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aspira Womens Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aspira to invest in growth at high rates of return. When we think about Aspira Womens' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Edwin DetrickCigna Corp
N/A
JD MDLaboratory
50
Christopher MBACigna Corp
N/A
Everett NevilleCigna Corp
59
Brian CaveneyLaboratory
47
AmirAli TalasazGuardant Health
44
Karl WagnerMednax Inc
49
William McDowellCigna Corp
N/A
C RichardsMednax Inc
50
Stephen AndersonLaboratory
N/A
ALAN MUNEYCigna Corp
63
Lisa UthgenanntLaboratory
57
Michael PhillipsCigna Corp
N/A
Matthew MandersCigna Corp
58
Stephen FarberMednax Inc
49
Dominic AndreanoMednax Inc
52
Adam PharmDCigna Corp
N/A
William KlitgaardLaboratory
61
Peter WilkinsonLaboratory
52
Nicole JonesCigna Corp
53
Lisa BacusCigna Corp
53
Aspira Womens Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. Aspira Womens Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas. Aspira Womans operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 106 people. Aspira Womens Health (AWH) is traded on NASDAQ Exchange in USA. It is located in Building III, Austin, TX, United States, 78738 and employs 85 people. Aspira Womens is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Aspira Womens Health Leadership Team

Elected by the shareholders, the Aspira Womens' board of directors comprises two types of representatives: Aspira Womens inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aspira. The board's role is to monitor Aspira Womens' management team and ensure that shareholders' interests are well served. Aspira Womens' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aspira Womens' outside directors are responsible for providing unbiased perspectives on the board's policies.
Wesley Dupont, Executive Vice President General Counsel
Susan Chmieleski, President of Allied World North American Healthcare
Emily Granger, Director Marketing
Robert CPA, Chief Officer
Sarah Doran, IR Contact Officer
Michael Newton, VP Commercial
Marlene McLennan, Interim Officer
James Duffy, Independent Director
John Gauthier, Executive Vice President Chief Investment Officer; President of Allied World Financial Services, Inc. and Allied World Financial Services, Ltd
Jody Berry, Chief Officer
Barbara Alexander, Independent Director
Patricia Guinn, Director
Nicole CPA, CEO President
Fiona Luck, Director
Gregory Richard, Sr Devel
Valerie Palmieri, Ex Chairwoman
Bart Friedman, Lead Independent Vice Chairman of the Board
Louis Iglesias, President of North America for Allied World Assurance Company (US) Inc and President of North America for Allied World National Assurance Company
Scott Carmilani, Chairman, CEO and President and Chairperson of Executive Committee
Julian James, President of Allied World Assurance Company (Europe) Limited
John McElroy, COO
Giuseppe Montefinese, IR Contact Officer
Michelle Snider, Senior Operations
Ryan MD, Chief Officer
Torsten Hombeck, Senior CFO
Eric Schwartz, Independent Director
Marshall Grossack, Executive Vice President Chief Actuary
Frank DOrazio, President of Underwriting and Global Risk
Dale Chow, Senior Vice President - Professional Lines of Allied World Bermuda
Patrick SaintAignan, Independent Director
Sean Rowe, VP Technology
Samuel Weinhoff, Independent Director
Kent Ziegler, Senior Vice President - Finance, Chief Accounting Officer
John Bender, President of Allied World Reinsurance Management Company
Minh Merchant, General Secretary
Thomas Bradley, CFO and Executive VP
Charles MD, Interim Officer

Aspira Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aspira Womens a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Aspira Womens

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aspira Womens position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aspira Womens will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aspira Stock

  0.71MMSI Merit Medical Systems Financial Report 24th of April 2024 PairCorr

Moving against Aspira Stock

  0.6NVNO EnVVeno Medical Corp Financial Report 6th of May 2024 PairCorr
  0.57FEMY Femasys Report 4th of April 2024 PairCorr
The ability to find closely correlated positions to Aspira Womens could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aspira Womens when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aspira Womens - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aspira Womens Health to buy it.
The correlation of Aspira Womens is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aspira Womens moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aspira Womens Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aspira Womens can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Aspira Womens Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aspira Womens' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aspira Womens Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aspira Womens Health Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aspira Womens Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for Aspira Stock analysis

When running Aspira Womens' price analysis, check to measure Aspira Womens' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspira Womens is operating at the current time. Most of Aspira Womens' value examination focuses on studying past and present price action to predict the probability of Aspira Womens' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aspira Womens' price. Additionally, you may evaluate how the addition of Aspira Womens to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stocks Directory
Find actively traded stocks across global markets
Transaction History
View history of all your transactions and understand their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Is Aspira Womens' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womens. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womens listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.66)
Revenue Per Share
1.054
Quarterly Revenue Growth
0.07
Return On Assets
(0.76)
Return On Equity
(3.46)
The market value of Aspira Womens Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womens' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womens' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womens' market value can be influenced by many factors that don't directly affect Aspira Womens' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womens' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aspira Womens is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womens' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.